Ascentage Pharma Group International reported total assets of $477.62M and total liabilities of $394.33M for the quarter ended Jun 2026, up 35.8% year over year. This balance sheet covers 5 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2023 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 153.91M | 172.81M | 231.93M | 353.07M | 279.37M |
| Cash & Current Investments | 153.91M | 172.81M | 231.93M | 353.07M | 279.37M |
| Receivables - NetNet Receivables | 20.53M | 11.39M | 10.94M | 36.15M | 23.05M |
| Receivables - OtherOther Receivables | 0.93M | 0.84M | 0.21M | ||
| Receivables | 21.46M | 12.23M | 10.94M | 36.36M | 23.05M |
| Finished Goods | 1.56M | 0.53M | 1.06M | ||
| Inventory | 2.27M | 0.90M | 1.20M | 4.09M | 9.48M |
| Current Deferred Tax AssetsCurrent Deferred Tax | 57.69M | 42.14M | 93.45M | 185.93M | 60.39M |
| Prepaid Assets | 12.42M | 16.88M | 22.38M | 27.52M | 26.08M |
| Current Assets | 189.13M | 201.99M | 266.45M | 420.83M | 337.99M |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net)PP&E (Net) | 127.45M | 116.39M | 114.64M | 111.67M | 110.76M |
| Long-Term Investments | 2.39M | 4.48M | 4.57M | 4.72M | 4.87M |
| Goodwill | 3.47M | 3.38M | 3.45M | 3.53M | 3.64M |
| Intangibles | 24.05M | 20.83M | 9.91M | 18.85M | 5.54M |
| Goodwill & Intangibles | 27.52M | 24.21M | 13.36M | 22.38M | 9.18M |
| Long-Term Deferred Tax | 8.42M | 6.06M | 4.66M | 6.40M | 2.71M |
| Other Non-Current Assets | 1.44M | 8.13M | 13.83M | 4.39M | 3.89M |
| Non-Current Assets | 162.69M | 156.68M | 158.78M | 145.77M | 139.64M |
| Assets | 351.82M | 358.67M | 425.23M | 566.60M | 477.62M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 10.19M | 12.60M | 16.57M | 15.26M | 15.76M |
| Payables | 10.19M | 12.60M | 16.57M | 15.26M | 15.76M |
| Accumulated Expenses | 0.58M | 2.03M | 0.39M | ||
| Other Accumulated Expenses | 4.00M | 35.37M | 34.81M | 39.55M | 34.18M |
| Current Taxes | 35.34M | 34.04M | 30.05M | ||
| Current Deferred Revenue | 5.40M | 5.14M | 5.23M | 5.36M | 10.25M |
| Total Current Liabilities | 131.44M | 159.85M | 252.23M | 234.90M | 277.59M |
| Non-Current Liabilities | |||||
| Non-Current Debt | 2.57M | ||||
| Non-Current Deffered Revenue | 5.12M | 3.77M | 0.93M | 0.93M | |
| Minority Interest | 1.44M | 1.37M | 1.39M | 1.39M | |
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 1.48M | 0.74M | |||
| Other Non-Current Liabilities | 0.86M | 1.07M | 1.72M | 1.05M | |
| Total Non-Current Liabilities | 210.44M | 161.28M | 140.93M | 116.49M | |
| Total Liabilities | 341.88M | 321.11M | 375.90M | 394.33M | |
| Shareholder's Equity | |||||
| Total Debt | 2.57M | ||||
| Common Equity | 9.94M | 37.57M | 190.71M | 83.29M | |
| Liabilities and Shareholders Equity | 351.82M | 358.67M | 425.23M | 566.60M | 477.62M |
| Treasury Shares | 3.00M | 0.00M | 0.42M | -2.41M | |
| Retained Earnings | -127.35M | -125.88M | -120.64M |
Pull Ascentage Pharma Group International's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=AAPG&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "AAPG", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=AAPG&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();